New approach increases the likelihood of detecting antiphosp

The Geneva University Hospitals, the University of Geneva and their spin-off Endotelix have created the best possible target molecule for the antibodies responsible for antiphospholipid syndrome.

Related Keywords

Geneva , Genè , Switzerland , Karim Brandt , Emily Henderson , Geneva University Hospitals , Cardiology Department , National Centre For Scientific Research , University Of Geneva , Lab Diagnostics Automation , Lab Diagnostics Automation Industry , Department Of Medicine , Automation Industry Focus , National Centre , Scientific Research , Antibodies , Antiphospholipid Syndrome , Yndrome , Flood , Contraception , Iagnostics , Heart , Medicine , Olecule , Pregnancy , Research , Hrombosis ,